These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 22123153)
1. Drug interaction in psycho-oncology: antidepressants and antineoplastics. Miguel C; Albuquerque E Pharmacology; 2011; 88(5-6):333-9. PubMed ID: 22123153 [TBL] [Abstract][Full Text] [Related]
2. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Spina E; Santoro V; D'Arrigo C Clin Ther; 2008 Jul; 30(7):1206-27. PubMed ID: 18691982 [TBL] [Abstract][Full Text] [Related]
3. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine. Owen JR; Nemeroff CB Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349 [TBL] [Abstract][Full Text] [Related]
4. [Interactions between metoprolol and antidepressants]. Molden E; Spigset O Tidsskr Nor Laegeforen; 2011 Sep; 131(18):1777-9. PubMed ID: 21946596 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant drugs in the elderly--role of the cytochrome P450 2D6. Vandel P World J Biol Psychiatry; 2003 Apr; 4(2):74-80. PubMed ID: 12692778 [TBL] [Abstract][Full Text] [Related]
6. [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani]. Gaillard R Encephale; 2009 Oct; 35(5):499-504. PubMed ID: 19853726 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of second generation antidepressants]. Grzesiak M; Beszłej JA; Kiejna A Psychiatr Pol; 2000; 34(4):577-94. PubMed ID: 11059258 [TBL] [Abstract][Full Text] [Related]
8. Risk and predictability of drug interactions in the elderly. Levy RH; Collins C Int Rev Neurobiol; 2007; 81():235-51. PubMed ID: 17433928 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of affective disorders in old age. Tourigny-Rivard MF Can J Psychiatry; 1997 Jun; 42 Suppl 1():10S-18S. PubMed ID: 9220125 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety. Taylor D Acta Psychiatr Scand; 2008 Dec; 118(6):434-42. PubMed ID: 18785947 [TBL] [Abstract][Full Text] [Related]
15. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study. Daniel WA; Kot M; Wójcikowski J Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100 [TBL] [Abstract][Full Text] [Related]
16. Desvenlafaxine and venlafaxine exert minimal in vitro inhibition of human cytochrome P450 and P-glycoprotein activities. Oganesian A; Shilling AD; Young-Sciame R; Tran J; Watanyar A; Azam F; Kao J; Leung L Psychopharmacol Bull; 2009; 42(2):47-63. PubMed ID: 19629022 [TBL] [Abstract][Full Text] [Related]
17. Potential for drug-drug interactions in treating cancer-related nausea and distress. Saylor MS; Smetana RF J Oncol Pharm Pract; 2011 Dec; 17(4):403-8. PubMed ID: 20889722 [TBL] [Abstract][Full Text] [Related]
18. The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression. Jann MW; Cohen LJ Drug Metabol Drug Interact; 2000; 16(1):39-67. PubMed ID: 10820582 [TBL] [Abstract][Full Text] [Related]
19. The safety of antidepressants. de Jonghe F; Swinkels JA Drugs; 1992; 43 Suppl 2():40-6; discussion 46-7. PubMed ID: 1378373 [TBL] [Abstract][Full Text] [Related]